_  A groundbreaking new test for the early detection of Alzheimer's disease is being developed at a research facility just north of Sydney, Australia.  Currently, the only prevalent tests of such             nature are invasive and expensive.  However, the test being developed in Syndey is a cheap       blood test that checks for a change in levels of a specific protein marker over a year in order to      determine if a patient is in deed affected by the lethal disease.  The earlier Alzheimer's is   detected, the more likely it can be slowed and even stopped. To learn more about Biomarkers and clinical symptoms of Alzheimer's Disease please visit Dr. Michael Mullan Roskamp Institute home page



Comments are closed.